Walden Behavioral Care, Inc. – Trademark Portfolio

Entity Type: 03

Walden Behavioral Care, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 9 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include WALDEN, CONTINUUM OF CARE, WALDEN BEHAVIORAL CARE, and LASTING RECOVERY FOR BODY AND MIND. The owner is based in Waltham, MA.

9 Hope Avenue, Suite 500

9 Hope Avenue, Suite 500

Waltham, MA 02453

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Walden Behavioral Care, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (9 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Walden Behavioral Care, Inc. have?

Walden Behavioral Care, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 4 cancelled.

What trademark classes does Walden Behavioral Care, Inc. file in?

Walden Behavioral Care, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Walden Behavioral Care, Inc.'s most well-known trademarks?

Walden Behavioral Care, Inc.'s registered trademark portfolio includes well-known marks such as WALDEN, CONTINUUM OF CARE, WALDEN BEHAVIORAL CARE, and LASTING RECOVERY FOR BODY AND MIND. These are among 5 currently registered trademarks in the portfolio.

What is Walden Behavioral Care, Inc.'s trademark registration success rate?

Walden Behavioral Care, Inc. has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.